KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
19.05
+0.83 (4.56%)
At close: Sep 26, 2025, 4:00 PM EDT
19.22
+0.17 (0.87%)
After-hours: Sep 26, 2025, 7:58 PM EDT
KALA BIO Market Cap
KALA BIO has a market cap or net worth of $133.75 million as of September 26, 2025. Its market cap has increased by 382.85% in one year.
Market Cap
133.75M
Enterprise Value
131.74M
1-Year Change
382.85%
Ranking
Category
Stock Price
$19.05
Market Cap Chart
Since July 20, 2017, KALA BIO's market cap has decreased from $430.50M to $133.75M, a decrease of -68.93%. That is a compound annual growth rate of -13.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 133.80M | 318.13% |
| Dec 31, 2024 | 32.00M | 69.31% |
| Dec 29, 2023 | 18.90M | -67.36% |
| Dec 30, 2022 | 57.90M | -26.99% |
| Dec 31, 2021 | 79.30M | -79.14% |
| Dec 31, 2020 | 380.20M | 198.20% |
| Dec 31, 2019 | 127.50M | -22.87% |
| Dec 31, 2018 | 165.30M | -63.54% |
| Dec 29, 2017 | 453.40M | 5.32% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 641.51B |
| Johnson & Johnson | 428.03B |
| AbbVie | 386.06B |
| UnitedHealth Group | 312.96B |
| Novo Nordisk | 251.02B |
| Novartis AG | 237.03B |
| Abbott Laboratories | 232.02B |
| AstraZeneca | 226.78B |